ARWR
Arrowhead Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$86.34
−0.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 64.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 26.20x
- Price / sales
- 18.22x
- Price / cash flow
- -206.52x
Enterprise value
- Enterprise value
- $11.5B
- EV / sales
- 17.12x
- EV / EBITDA
- -81.66x
- EV / EBIT
- -50.60x
- Market cap
- $12.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026